Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Jorne Lionel Biccler, MSc, BSc, Ingrid Glimelius, MD PhD, Sandra Eloranta, Knut B. Smeland, Peter de Nully Brown, MD PhD, Lasse H. Jakobsen, Henrik Frederiksen, MD PhD, Mats Jerkeman, Alexander Fosså, MD PhD, Therese M.L. Andersson, PhD, Harald Holte, Jr., MD PhD, Martin Bøgsted, Professor, Tarec C. El-Galaly, Karin Ekstroem Smedby, MDPhD

Blood (2018) 132 (Supplement 1): 930.

https://doi.org/10.1182/blood-2018-99-111759

Published: 2018

Journal Articles

Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma

Jorne Lionel Biccler, MSc, BSc, Kerry J Savage, BSc, MD MSc, Peter de Nully Brown, MD PhD, Judit Jørgensen, MD PhD, Thomas Stauffer Larsen, MD PhD, Christian Bjørn Poulsen, MD, Danny Stoltenberg, MD, Lasse H. Jakobsen, Martin Bøgsted, Professor, Diego Villa, MD, Tarec C. El-Galaly

Blood (2018) 132 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2018-99-114191

Published: 2018

Journal Articles

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

Allison Barraclough, MBBS, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris Van Vliet, Laurie H. Sehn, MDMPH, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Pedro Farinha, Jorne Lionel Biccler, MSc, Joseph M Connors, MD, David W. Scott, MD PhD FRACP, FRCPA, Kerry J Savage, MD, Tarec Christoffer El-Galaly, MD PhD, Diego Villa, MD, Chan Yoon Cheah

Blood (2017) 130 (Supplement 1): 415.

https://doi.org/10.1182/blood.V130.Suppl_1.415.415

Published: 2017

Journal Articles

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Jorne Lionel Biccler, MSc, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MD PhD, Claus Werenberg Marcher, MD PhD, Peter Møller, MD, Claudia Schöllkopf, MD PhD, Lone Smidstrup Friis, MD PhD, Lasse Hjort Jakobsen, MSc, Tarec Christoffer El-Galaly, MD PhD, Jan M. Nørgaard, MD PhD

Blood (2017) 130 (Supplement 1): 2595.

https://doi.org/10.1182/blood.V130.Suppl_1.2595.2595

Published: 2017

Journal Articles

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Tove Wästerlid, MD PhD, Jorne Lionel Biccler, MSc, Peter de Nully Brown, MD PhD, Jacob Haaber Christensen, MD PhD, Gunilla Enblad, MD PhD, Judit Mészáros Jørgensen, Karin E Smedby, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Mats Jerkeman, MD PhD

Blood (2017) 130 (Supplement 1): 1560.

https://doi.org/10.1182/blood.V130.Suppl_1.1560.1560

Published: 2017

Journal Articles

Routine Follow-up Visits for Chronic Lymphocytic Leukemia Managed Initially By Watch and Wait Rarely Lead to Interventions: A North Denmark Population-Based Study

Caroline Holm Nørgaard, BSc, Nikoline Buus Søgaard, BSc, Jorne Lionel Biccler, MSc, Laura Pilgaard, BSc, Mathias Holmsgaard Eskesen, BSc, Thordis Helga Kjartansdóttir, BSc, Hans Erik Johnsen, MD Professor, Martin Bøgsted, Professor, Mette Dahl Bendtsen, MSc, Tarec Christoffer El-Galaly, MD PhD

Blood (2017) 130 (Supplement 1): 5330.

https://doi.org/10.1182/blood.V130.Suppl_1.5330.5330

Published: 2017

NARROW

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Routine Follow-up Visits for Chronic Lymphocytic Leukemia Managed Initially By Watch and Wait Rarely Lead to Interventions: A North Denmark Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Routine Follow-up Visits for Chronic Lymphocytic Leukemia Managed Initially By Watch and Wait Rarely Lead to Interventions: A North Denmark Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only